Short Interest in Applied Dna Sciences Inc (NASDAQ:BNBX) Declines By 64.2%

Applied Dna Sciences Inc (NASDAQ:BNBX) was the recipient of a significant drop in short interest during the month of April. As of April 30th, there was short interest totaling 231,818 shares, a drop of 64.2% from the April 15th total of 647,929 shares. Currently, 4.4% of the shares of the stock are short sold. Based on an average daily trading volume, of 3,279,719 shares, the short-interest ratio is presently 0.1 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Applied Dna Sciences in a report on Friday, April 24th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Applied Dna Sciences Price Performance

BNBX stock traded down $0.01 during mid-day trading on Friday, reaching $0.46. 27,042 shares of the stock traded hands, compared to its average volume of 627,888. The firm has a market cap of $2.61 million, a PE ratio of 0.00 and a beta of 0.58. Applied Dna Sciences has a one year low of $0.45 and a one year high of $12.09. The company has a 50-day simple moving average of $0.62.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.